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Abstract
Background: The lack of a patent source of infection after 24 hours of management of shock considered septic
is a common and disturbing scenario. We aimed to determine the prevalence and the causes of shock with no
diagnosis 24 hours after its onset, and to compare the outcomes of patients with early-confirmed septic shock to
those of others.
Methods: We conducted a pragmatic, prospective, multicenter observational cohort study in ten intensive care
units (ICU) in France. We included all consecutive patients admitted to the ICU with suspected septic shock defined
by clinical suspicion of infection leading to antibiotic prescription plus acute circulatory failure requiring vasopressor
support.
Results: A total of 508 patients were admitted with suspected septic shock. Among them, 374 (74 %) had early-
confirmed septic shock, while the 134 others (26 %) had no source of infection identified nor microbiological
documentation retrieved 24 hours after shock onset. Among these, 37/134 (28 %) had late-confirmed septic shock
diagnosed after 24 hours, 59/134 (44 %) had a condition mimicking septic (septic shock mimicker, mainly related
to adverse drug reactions, acute mesenteric ischemia and malignancies) and 38/134 (28 %) had shock of unknown
origin by the end of the ICU stay. There were no differences between patients with early-confirmed septic shock
and the remainder in ICU mortality and the median duration of ICU stay, of tracheal intubation and of vasopressor
support. The multivariable Cox model showed that the risk of day-60 mortality did not differ between patients
with or without early-confirmed septic shock. A sensitivity analysis was performed in the subgroup (n = 369/508)
of patients meeting the Sepsis-3 definition criteria and displayed consistent results.
Conclusions: One quarter of the patients admitted in the ICU with suspected septic shock had no infection
identified 24 hours after its onset and almost half of them were eventually diagnosed with a septic shock
mimicker. Outcome did not differ between patients with early-confirmed septic shock and other patients.
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Background
The lack of a patent source of infection and/or the
absence of microbiological documentation is not uncom-
mon during the first hours of management of patients
presenting with a clinical phenotype of septic shock.
Study of a large series of patients with sepsis in the in-
tensive care unit (ICU) [1–3] reveals that approximately
5 % of patients with shock initially deemed to be septic
had neither source of infection nor microbiological
documentation retrieved by the end of the ICU stay,
raising the question whether these patients truly had an
underlying infection. In a monocentric study, Heffner et
al. [4] showed that 18 % of patients diagnosed with sep-
sis had in fact a non-infectious condition that mimicked
sepsis (sepsis mimicker). Two previous retrospective
studies [5, 6] both showed that 13 % of the patients ad-
mitted to the ICU with suspected sepsis had in fact no
infection identified; interestingly, these patients had a
higher mortality rate as compared with those having an
identified infection. The causes of sepsis mimickers are
numerous and typically include adrenal insufficiency,
acute pancreatitis, drug adverse effects, lymphoma,
hemophagocytic lymphohistiocytosis or tumor lysis
syndrome [4, 7].
The presence of an infectious process is by definition
necessary to discriminate between sepsis and sepsis
mimickers. However, patients with sepsis mimickers
have a clinical phenotype that resembles that of patients
with sepsis, so that antimicrobial agents are usually
administered within the first hours of recognition of
shock [8], until infection is ruled out and an alternative
non-infectious diagnosis is made.
Managing a patient with a clinical phenotype of septic
shock and with no clear diagnosis (lack of both a source
of infection and microbiological documentation) within
the first 24 hours of vasopressor introduction is a com-
mon but disturbing and challenging clinical scenario
reflected by the often quoted question “what does my
patient have?” heard during morning rounds in many
ICUs. To our knowledge, the prevalence, the causes and
the prognosis of suspected septic shock with no early
(i.e., 24 h after vasopressor introduction) etiological
diagnosis (i.e., non-early-confirmed septic shock) have
never been assessed in a large series.
We conducted a pragmatic, prospective, multicenter,
observational cohort study including patients initially
considered to have septic shock, in which we aimed
to: (1) determine the prevalence of non-early-
confirmed septic shock, as defined by the lack of a
definite source of infection and microbiological docu-
mentation within 24 h of shock onset; (2) identify the
main causes of non-early-confirmed septic shock; and
(3) compare the outcome of patients with and with-
out early-confirmed septic shock.
Methods
Patients
We conducted a pragmatic, multicenter, observational,
prospective cohort study in 10 ICUs in France. From
November 2014 to June 2015 all consecutive patients with
suspected septic shock requiring ICU admission were in-
cluded. Suspected septic shock was defined by clinical sus-
picion of infection leading to antibiotic prescription, plus
acute circulatory failure requiring vasopressor support [9]
(norepinephrine or epinephrine) for more than 1 mg/h
and more than 1 h. Patients with post-chemotherapy neu-
tropenia, hemorrhagic shock, obstructive or non-septic
cardiogenic shock and patients developing post-operative
shock or shock post cardiac arrest were excluded. Patients
with ICU-acquired septic shock (i.e., occurring more than
48 h after ICU admission) were also excluded.
Within the context of this pragmatic study reflecting
real-life practice, the diagnostic work-up was not proto-
colized, and microbiological and imaging studies were
performed at the discretion of the attending physician
(see Additional file 1). Serum biomarkers, including C-
reactive protein or procalcitonin were not routinely
measured. In the case of lethal shock of unknown origin,
an autopsy was encouraged.
Patients’ management
All patients were promptly treated with broad-spectrum
antibiotic therapy, according to the source of suspected
infection, previous antibiotic treatment, and known
colonization with multidrug-resistant bacteria. Source
control measures, such as surgery or removal of infected
devices, were applied when necessary. Patients were
treated according to the 2013 guidelines of the Surviving
Sepsis Campaign [8]. Low-dose steroids (hydrocortisone)
were prescribed at the discretion of the clinician.
Categorization of patients
The investigator of each center participating in the study
was responsible for prospectively categorizing patients
into two groups, according to data available at 24 h of in-
clusion: (1) patients with proven septic shock (i.e., a likely
source of infection was identified by clinical or imaging
studies and/or microbiological documentation was ob-
tained within the first 24 h) were categorized as having
early-confirmed septic shock (EC-SS); and (2) patients
with no definite infection identified (i.e., absence of both a
source of infection and microbiological documentation
within the first 24 h) were categorized as having non-
early-confirmed septic shock (non EC-SS) (Fig. 1).
Definition of infection
Definitions of infection are provided in Additional file 1,
and were used for the post-hoc classification of the
sources of infection identified in patients with early-
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confirmed and late-confirmed septic shock. For all
sources of infection, the absence of microbiological
documentation did not per se exclude sepsis.
Collection of data
Details about collected data are available in Additional
file 1.
Statistical analysis
Quantitative variables were expressed as median (25th–
75th percentiles) unless otherwise stated, and the nom-
inal variables were reported as number (percentage).
The quantitative variables were compared using the
unpaired Student’s t test or the Mann-Whitney U test,
and the nominal variables were compared using the chi-
square (χ2) test or the Fisher exact test, as appropriate.
The outcome of patients with EC-SS was compared to
that of patients with non EC-SS. Mortality over the
follow-up period was analyzed using a multivariable Cox
model including variables yielding a p value <0.10 in
univariable analysis. Potential interactions between vari-
ables introduced in the model and centers were tested
using the Mantel-Haenszel test of homogeneity of odds
ratios; no significant interaction was detected. Follow up
was censored at the date of latest information or at 60
days, whichever occurred first. Every effort was made to
obtain the post-ICU/hospital discharge vital status from
investigators at each site. Survival curves were generated
using the Kaplan–Meier method and compared between
patients with EC-SS and non EC-SS using the log-rank
test. Sensitivity analysis was performed to assess the
validity of our results (i.e., proportion of patients with
EC-SS and non EC-SS and Cox model for determining
factors associated with mortality) in the subgroup of
patients meeting septic shock criteria, as defined by the
Third International Consensus Definitions for Sepsis
and Septic Shock [10] (Sepsis-3). Missing data were
retrieved from queries to the investigators. There was no
imputation of missing data, except for data missing from
comorbidities, which were then considered as absent. A
two-way p value <0.05 was considered significant. Statis-
tical analysis was performed using the statistical software
package STATA version 13.1 (Stata Corp., College
Station, TX, USA).
Results
One of four patients admitted in the ICU with a suspicion
of septic shock had no infection identified at 24 h of
shock onset
From November 2014 to June 2015, 508 patients
with suspected septic shock were admitted to 10
ICUs. Among these 508 patients, 374 (74 %, 95 % CI
70–78) had EC-SS, whereas the remaining 134 (26 %,
95 % CI 22–30) lacked early confirmation (non EC-
SS) (Fig. 1). There were no differences in demo-
graphic data and associated comorbidities between
patients with EC-SS and patients with non EC-SS,
except for diabetes mellitus, which was more fre-
quent in the latter group (Table 1).
Fig. 1 Flow chart. *Shock with no source of infection nor microbiological documentation at 24 h of study inclusion
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Patients with non EC-SS underwent more diagnostic
testing
Patients with non EC-SS underwent more imaging
procedures, including computed tomography (CT) of
the chest and abdomen and echocardiography,
during the first 24 h of shock management, as
compared to those with EC-SS (see Additional file 1:
Table S1). Likewise, among the microbiological tests
performed, urine, pleural and lumbar cultures were
more frequently obtained in patients with non EC-SS
as compared to those with EC-SS (Additional file 1:
Table S1).
Table 1 Baseline characteristics of patients admitted to the ICU with suspected septic shock (n = 508) and comparison between
patients with early-confirmed septic shocks (EC-SS) and other patients (non EC-SS)
All patients (n = 508) EC-SS (n = 374) Non EC-SS (n = 134) P
Age and gender
Age, years 68 (59–79) 67 (58–80) 68 (61–78) 0.81
Male gender 297 (58) 219 (59) 78 (58) >0.99
Comorbidities
Chronic respiratory disease 21 (4) 17 (5) 4 (3) 0.44
Chronic heart failure 34 (7) 22 (6) 12 (9) 0.22
Chronic kidney disease 46 (9) 33 (9) 13 (10) 0.76
Cirrhosis 49 (10) 35 (9) 14 (10) 0.71
Recent malignant hemopathy 34 (7) 27 (7) 7 (5) 0.43
Recent cancer 63 (12) 43 (11) 20 (15) 0.30
Diabetes mellitus 132 (26) 87 (23) 45 (34) 0.019
HIV infection 17 (3) 11 (3) 6 (4) 0.40
Obesity 71 (14) 54 (14) 17 (13) 0.62
Cerebrovascular disease 55 (11) 37 (10) 18 (13) 0.26
Immunosuppressive therapy 54 (11) 41 (11) 13 (10) 0.68
Immunosuppression statusa 132 (26) 95 (25) 37 (28) 0.62
No coexisting comorbid conditions 154 (30) 119 (32) 35 (26) 0.22
Clinical data within 24 h of inclusion and antibiotic therapy
Maximal temperature, °C 38.2 (37.3–39.0) 38.4 (37.4 − 39.1) 37.9 (36.9 − 38.6) <0.0001
Minimal temperature, °C 36.1 (35.2–37.0) 36.2 (35.4–37.0) 36.0 (34.6–36.8) 0.006
Glasgow Coma Scale 14 (11–15) 15 (12–15) 13 (9–15) 0.002
SAPS2 58 (47–73) 58 (45–72) 59 (50–75) 0.34
Delay admission-inclusion, hours 1 (0–6) 2 (0–7) 1 (0–4) 0.33
Delay inclusion -ATB1, hours 0 (0–1) 0 (0–1) 0 (0–1) 0.28
Delay inclusion -ATB2, hours 0 (0–2) 0 (0–2) 0 (0–2) 0.59
Number of ATB administered at 3 h 2 (1–2) 2 (1–2) 2 (1–2) 0.09
Number of ATB administered at 24 h 2 (2–3) 2 (2–3) 2 (1–3) 0.050
Biological data within 24 h of inclusion
Leukocyte count, 103.mm−3 16.5 (9.9–24.6) 17.1 (9.8–24.9) 15.9 (9.9–23.0) 0.62
Platelets count, 103/mm−3 156 (85–243) 156 (81–45) 155 (92–236) 0.72
C-reactive protein, mg/Lb 166 (87 − 265) 178 (110 − 288) 108 (48–179) <0.0001
Procalcitonin, ng/mLc 7.6 (1.3–37.9) 19.6 (3.7–56.5) 1.6 (0.7–7.8) <0.0001
Serum urea, mmol/L 14.0 (8.7–21.7) 13.6 (8.7–20.0) 16.0 (9.1–24.0) 0.16
Serum creatinine, μmoL/L 187 (114–296) 187 (115–275) 198 (107–347) 0.13
Prothrombin time, % 58 (41–72) 58 (42–72) 56 (38–72) 0.72
Arterial lactate, mmol/L 3.5 (2.0–7.0) 3.4 (2.0–6.1) 3.6 (2.0–10.0) 0.13
Categorical variables are expressed as number (%) and continuous variables as median (IQR 25–75). aImmunosuppression status includes patients with HIV or
malignant hemopathy or recent cancer, or under immunosuppressive therapy. bValue available for 248 patients. cValue available for 128 patients. ATB antibiotic
therapy, h hour, HIV human immunodeficiency virus, SAPS2 Simplified Acute Physiology Score, WBC white blood count
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Patients with non EC-SS had predominantly non-
infectious disease
Only 37 (28 %) of the 134 patients with non EC-SS had
infectious etiology, which was identified after a median
delay of 2 (IQR 1–2) days following inclusion (late-
confirmed septic shocks (LC-SS)), whereas 59 patients
(44 %) had non-infectious etiology identified within 2
(1–4) days (septic shock mimickers (SSM)) and 38
patients (28 %) remained with no diagnosis by the
end of the ICU stay (shock of unknown origin
(SUO)) (Fig. 1 and Table 2). Causes of shock in
patients with non EC-SS are shown in Table 2.
For patients with confirmed infection (i.e., the EC-SS
and LC-SS groups), the source of infection and the mi-
croorganisms isolated are reported in Additional file 1:
Tables S2, S3 and S4). In both the EC-SS and LC-SS
groups, the main source of infection identified was
pleuro-pulmonary (Additional file 1: Table S2), including
33 % of patients (n = 65/195) having no microbiological
documentation. Among patients (n = 313) who were not
diagnosed with pleuro-pulmonary infection, 52 (17 %)
presented with pulmonary infiltrates on chest x-ray.
There was no significant difference observed between
EC-SS and non EC-SS patients in the proportion of
patients with leucocytes in otherwise sterile body fluids
(Additional file 1: Table S5).
Day-60 mortality was not different between EC-SS and
non EC-SS patients
Patients with EC-SS developed acute respiratory distress
syndrome (ARDS) more frequently thanthe other
patients, although the requirement of mechanical venti-
lation did not differ between EC-SS and non EC-SS pa-
tients. Conversely, the non EC-SS group required renal
replacement therapy more frequently (Table 3). There
were no differences between these two groups in ICU
mortality, duration of ICU stay and duration of mechan-
ical ventilation or of vasopressor support (Table 3).
The median follow up of patients included in the
cohort was 33 (6–98) days in the whole cohort and 93
(55–144) days in survivors. Among patients who sur-
vived to ICU discharge (n = 320), 74 had follow up of
under 60 days (median 36 (26–53) days) and were
censored at the time of the latest follow up. The
Kaplan–Meier plot of the probability of survival from
inclusion to day 60 showed no significant difference
between patients with EC-SS and patients with non EC-
SS (Fig. 2; p = 0.41, log-rank test), which was confirmed
by the multivariable Cox model after adjusting for covar-
iates associated with mortality and taking into account
the center effect (Table 4). However, when patients with
non EC-SS were categorized as LC-SS, SSM or SUO,
those from the latter subgroup had a lower probability
of survival than the others (Additional file 1: Figure S1;
Table 2 Causes of shock in the 134 patients with non-early-
confirmed septic shock (non EC-SS, i.e., patients with shock but
no source of infection or microbiological documentation at 24
h after onset of shock)
Causes Number (%)
Late-confirmed septic shock (LC-SS), n/total study sample (%) 37/134 (28)
Pleuro-pulmonary 13/37 (35)
Urinary tract 6/37 (16)
Abdomen 4/37 (11)
Liver and biliary tract 4/37 (11)
Primary bloodstream infection 4/37 (11)
Skin and soft tissues 2/37 (5)
Endocarditis 1/37 (3)
Bone-joint 1/37 (3)
Central nervous system 1/37 (3)
Endovascular stent infection 1/37 (3)
Septic shock mimickers (SSM), n/total study sample (%) 59/134 (44)
Adverse effects of drugs 22/59 (37)
Metformin 10
Angiotensin-converting enzyme inhibitors











Solid tumor (including one Marastic endocarditis) 4
Tumor lysis syndrome 2
Inflammatory diseases 5/59 (8)
Hemophagocytic lymphohistiocytosis 2
Drug rash with eosinophilia and systemic symptoms 1
Catastrophic antiphospholipid syndrome 1
Cholesterol embolization syndrome 1
Metabolic disorders 4/59 (7)
Acute adrenal insufficiency 2
Diabetic ketoacidosis 2
Acute pancreatitis 4/59 (7)
Miscellaneous 3/59 (5)
Abdominal compartment syndrome 1
Air embolismb 1
“Reventilation” syndrome 1
Shock of unknown origin (SUO), n/total study sample (%) 38/134 (28 %)
Categorical variables are expressed as n (%). aIncluding neuroleptic (n = 1),
lithium (n = 1), intravenous immunoglobulins (n = 1), sorafenib (n = 1).
bAir embolism was clinically suspected and confirmed by autopsy
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p = 0.014, log-rank test). The multivariable Cox model
confirmed that patients categorized as having SUO had
higher risk of mortality (Additional file 1: Table S6).
Sensitivity analysis assessing the validity of the results in
the subgroup of patients meeting the criteria of the
Sepsis-3 definition
Among the 508 included patients with septic shock ac-
cording to the 1992 definition [9], 369 (73 %) had serum
lactate levels greater than 2 mmol/L and thus met the
septic shock criteria of the Sepsis-3 definition [10]. In
this subgroup, the distribution of patients with EC-SS
(n = 272 (74 %), 95 % CI 69–78) and non EC-SS (n =
97 (26 %), 95 % CI 21–30) was remarkably similar
with that of the whole cohort. Moreover, among pa-
tients with non EC-SS, the proportion of those with
LC-SS (n = 23 (24 %), 95 % CI 15–32), SSM (n = 43
(44 %), 95 % CI 34–54), and SUO (n = 31 (32 %), 95 % CI
23–41) was also consistent with that observed in the
whole cohort (Additional file 1: Table S7).
A multivariable Cox model was run in this subgroup
and displayed results consistent with those in the whole
cohort, with no significant relationship between non EC-
SS and day-60 mortality (Additional file 1: Table S8).
Also, when patients with non EC-SS were categorized
as LC-SS, SSM or SUO, those from the latter sub-
group had higher risk of mortality than the other
patients (Additional file 1: Table S9), consistent with
the results obtained in the whole cohort.
Discussion
The main results of our pragmatic study are as follows:
(1) a quarter of patients admitted to ICUs with sus-
pected septic shock had no infection identified at 24 h
after onset of shock and almost half of them had a septic
shock mimicker; (2) septic shock mimickers were mostly
due to acute mesenteric ischemia or adverse effects of
drugs; and (3) outcomes did not differ between EC-SS
and non EC-SS patients.
We reported a high rate (26 %) of patients admitted to
the ICU with suspected septic shock and no clear diag-
nosis 24 h after its onset. This 24-h time point was
defined a priori because we believed it relevant to the
management of patients with sepsis syndromes, as it
practically corresponds to the end of the initial manage-
ment phase of critically ill patients admitted to the ICU
and the time when most patients receive a probable/
confirmed diagnosis. We also show that in almost three
quarters of these cases (i.e., patients with SUO and SSM,
accounting for 19 % of the whole cohort), sepsis was not
eventually identified, despite an extensive diagnostic
work-up with more imaging procedures and microbio-
logical investigations, which is consistent with the 18 %
Fig. 2 Kaplan–Meier plot of the probability of survival from inclusion
to day 60 in patients with early-confirmed septic shock (EC-SS, blue
curve) and other patients (Non EC-SS, red curve)
Table 3 Organ support and outcomes in patients admitted to the ICU with suspected septic shock (n = 508) and comparison
between patients with early-confirmed septic shock (EC-SS) or non-early confirmed septic shock (Non EC-SS)
All patients (n = 508) EC-SS (n = 374) Non EC-SS (n = 134) P
Tracheal intubation 397 (78) 294 (79) 103 (77) 0.67
ARDS 167 (33) 143 (38) 24 (18) <0.0001
Renal replacement therapy 145 (28) 95 (25) 50 (37) 0.009
Steroids for septic shocka 197 (39) 143 (38) 54 (40) 0.67
ECMO 8 (2) 5 (1) 3 (2) 0.44
Duration of tracheal intubation, days 4 (1 − 9) 4 (1 − 9) 4 (0 − 6) 0.19
Duration of vasopressors support, days 3 (2 − 5) 3 (2 − 5) 3 (2 − 6) 0.55
Duration of ICU stay, days 7 (4 − 14) 7 (4 − 24) 7 (4 − 21) 0.69
ICU mortality 188 (37) 139 (37) 49 (37) 0.90
Follow-up duration, days 29 (7 − 96) 30 (8 − 91) 25 (6 − 113) 0.75
Mortality over the follow-up period 232 (46) 166 (44) 66 (49) 0.33
Categorical variables are expressed as n (%) and continuous variables as median (IQR 25–75). aIncludes eight patients receiving either steroids or placebo because
of clinical trial enrolment.
ARDS acute respiratory distress syndrome, ECMO extra-corporeal membrane oxygenation, ICU Intensive Care Unit
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rate reported by Heffner et al. [4] in the emergency de-
partment. Interestingly, the prevalence of diabetes melli-
tus was higher in patients with non EC-SS as compared
to those with EC-SS, likely because of the large propor-
tion of patients with metformin intoxication, which
might also explain the higher rate of renal replacement
therapy observed in this group. Conversely, the rate of
ARDS was higher in patients with EC-SS, consistent
with the fact that pulmonary sepsis, known to be one of
the main risk factors for ARDS [11, 12], was the source
of infection in half of cases in this group.
Our results thus suggest that the lack of either a
source of infection or microbiological documentation,
identified at 24 h after vasopressor introduction in
patients admitted to and treated in the ICU on clinical
suspicion of septic shock, should encourage practitioners
to consider the possibility of a sepsis mimicker, which in
the current study accounted for almost half of the pa-
tients in that group. In other words, more than 90 % of
patients with confirmed septic shock were diagnosed
within 24 h of the onset of shock and infection was sec-
ondarily confirmed in only 28 % of patients with shock
having no clear diagnosis at 24 h. Our study illustrates
the wide differential diagnostic spectrum of patients pre-
senting with a clinical phenotype of septic shock.
Practically, when the etiology of a sepsis syndrome
appears unclear, our series provides managing physi-
cians with a useful working list of the main sepsis
mimickers among medical admissions. The main
causes of sepsis mimickers found in our study were
classic [7], with a high proportion of adverse drug re-
actions, acute mesenteric ischemia, malignancies and
inflammatory diseases.
Another important finding of the current study is
that 7 % of the patients admitted to the ICU with
suspected septic shock had shock of unknown origin
and that both the ICU mortality and the 60-day mor-
tality rates in these patients were higher than in other
Table 4 Factors associated with day-60 mortality in univariable and multivariable Cox models
Variables Univariable analysis Multivariable analysisa
HR (95 % CI) P HR (95 % CI) P
Categorization of shock
EC-SS 1 - -
Non EC-SS 0.87 (0.65–1.16) 0.34
Cirrhosis
No 1 1
Yes 2.04 (1.42–2.93) <0.0001 2.45 (1.63–3.69) <0.0001
Cancer
No 1 1
Yes 1.62 (1.15–2.28) 0.006 1.91 (1.32–2.75) <0.001
Chronic respiratory failure
No 1 1
Yes 2.16 (1.30–3.59) 0.003 2.45 (1.41–4.26) 0.002
Age >68 years
No 1 1
Yes 1.47 (1.14–1.91) <0.0001 1.73 (1.30–2.30) <0.0001
SAPS2 > 58
No 1 1
Yes 3.01 (2.28–3.96) <0.0001 1.94 (1.43–2.64) <0.0001
PT ratio <50%
No 1 1
Yes 1.96 (1.50–2.55) <0.0001 1.41 (1.05–1.91) 0.024
Mechanical ventilation
No 1 1
Yes 3.65 (2.33–5.72) <0.0001 2.53 (1.57–4.09) <0.0001
Lactate, per point in mmol/L 1.09 (1.07–1.11) <0.0001 1.06 (1.04–1.09) <0.0001
Patients were categorized as having early-confirmed (i.e., within 24 h of vasopressor initiation) septic shock (EC-SS) or not (non EC-SS). aAdjusted for center.
CI confidence interval, HR hazard ratio, PT prothrombin time, SAPS2 simplified acute physiology score 2
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patients, including those with a septic shock mim-
icker. This 7 % rate is comparable to the 5 % rate of
patients with no source of infection or microbio-
logical identification reported in previous large sepsis
studies [1–3], raising the question whether these
patients truly had an underlying infection.
The reason for the higher risk of mortality observed
in the SUO subgroup likely involves the lack of avail-
able etiological diagnosis and consequently, the im-
possibility of promptly initiating targeted treatment to
reverse shock. In the ICU setting, autopsy studies
[13–15] have been performed to assess the discrepan-
cies between clinical and post-mortem diagnoses.
Nevertheless, there is scant information in the litera-
ture on the rates of autopsy performed to identify the
etiology of lethal shock. Unfortunately, none of our
patients who died of shock of unknown origin under-
went post-mortem imaging and only one of the three
autopsies performed allowed a definite diagnosis (air
embolism). Previous autopsy studies suggest that pa-
tients with lethal shock of unknown origin may have
died from an undiagnosed vascular disease or acute
hemorrhage, which are the main causes of missed
diagnoses in the ICU setting [13]. In the context of a
worldwide decline in the autopsy rate [16, 17], virtual
autopsy involving post-mortem multidetector CT or
magnetic resonance imaging (MRI) combined with 3D
visualization may be a new alternative to medical
autopsy [17, 18].
Our study has several limitations. First, the 24-h delay
after onset of shock that was used to categorize patients
into the EC-SS or the non EC-SS groups may be consid-
ered too short as definitive cultures of microbiological
samples are not available by then. However, this delay
had been defined a priori for its practical clinical rele-
vance and eventually, only 9 % of patients with septic
shock were confirmed after 24 h.
Second, patients with acute mesenteric ischemia
were categorized as having SSM, which may be ques-
tionable. Nevertheless, 10 of the 12 patients diagnosed
with acute mesenteric ischemia in the current series
underwent surgery and had no evidence of digestive
perforation or peritonitis. Moreover, all 12 patients
had blood cultures drawn, none of which was posi-
tive, and 4 of 10 patients who underwent surgery had
peritoneal cultures tested, and all remained sterile.
Interestingly, a large recent observational study [19]
showed that antibiotic therapy, although widely pre-
scribed, is not associated with reduction of mortality
in patients with acute mesenteric ischemia, thus
downplaying the role of infection during acute mesen-
teric ischemia.
Third, a few causes of SSM may appear question-
able, including ketoacidosis, reventilation syndrome or
propofol-associated hypotension not meeting the diag-
nostic criteria for propofol infusion syndrome [20];
however, all these patients received antibiotics on
clinical suspicion of sepsis and none of them had
either microbiological documentation or a source of
infection identified.
Fourth, one cannot rule out the possibility that
some of the patients eventually diagnosed with SUO
had in fact an unidentified infection [1, 21]. However,
these patients had no source of infection or microbio-
logical documentation identified by the end of the
ICU hospitalization in spite of a comprehensive diag-
nostic work-up. We acknowledge that conventional
microbiological methods frequently fail to identify a
microorganism due to various reasons related to tech-
nical issues or intrinsic to the microorganism. Using
polymerase chain reaction methods might have im-
proved the early diagnosis of sepsis and helped rule
out infection within 6 h of ICU admission [22, 23].
Of note, despite the limited number of patients inves-
tigated in this regard, plasma procalcitonin levels
were lower in patients with SUO, suggesting the ab-
sence of an infectious process. Moreover, Combes et
al. [13] previously showed that cardiovascular disease
was the leading cause of missed clinical diagnoses, as
opposed to infectious disease, which accounted for
only 10 % of the autopsy-identified missed clinical
diagnosis.
Last, the current study was designed two years be-
fore the publication of the Sepsis-3 definition [10],
and the inclusion of patients was closed before its
publication [10]. Thus, the quick version of the se-
quential organ failure assessment (SOFA) was not
collected upon admission. Additionally, although all
patients met the criteria for the previous definition of
septic shock [9], approximately one fourth (n = 139)
of the included patients had no hyperlactacidemia
(i.e., serum lactate >2 mmol/L) upon ICU admission
and would thus not have met the criteria for the
Sepsis-3 definition. In any case, sensitivity analysis
was performed in the subgroup of patients meeting
the Sepsis-3 criteria and yielded remarkably consistent
findings with those obtained from the analysis of the
whole cohort.
Conclusion
Our study showed that using conventional microbio-
logical methods, one quarter of the patients admitted to
the ICU with clinical presentation of septic shock had
no infection identified 24 h after introduction of vaso-
pressors, and almost half of these patients had a non-
infectious diagnosis that mimicked sepsis. We identified
several causes of septic shock mimickers for which
patients with suspected septic shock of no apparent
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etiology should be screened. Outcomes did not differ
between patients with early-confirmed septic shock and
other patients. Seven percent of the patients admitted
on suspicion of septic shock had no cause identified by
the end of ICU stay. Further studies are needed to assess
the diagnostic yield of molecular detection methods in
this subgroup of patients.
Key messages
 One quarter of the patients admitted to the ICU on
suspicion of septic shock had no infection identified
24 h after onset of shock.
 Almost half of the patients with no infection
identified 24 h after onset of shock had a
non-infectious disease that mimicked sepsis.
 The main causes of septic shock mimickers were
adverse effects of drugs, malignancies, acute
mesenteric ischemia and inflammatory diseases.
 Outcomes did not differ between patients with
and without early-confirmed septic shock.
 Seven percent of the patients admitted to the ICU
on suspicion of septic shock had shock of unknown
origin.
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